Hi @davidpball, I expanded the title of your discussion to hopefully attract more responses. As you likely know, Adstiladrin (nadofaragene firadenovec-vncg) was recently approved for bladder cancer. It is a gene therapy currently used for adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC).

David, is Adstiladrin a treatment option for you?